60 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O
or 25 27 25 27 O
50 28 30 28 30 B-lower_bound
- 30 31 30 31 O
59 31 33 31 33 B-upper_bound
with 34 38 34 38 O
a 39 40 39 40 O
low 41 44 41 44 O
Oncotype 45 53 45 53 B-clinical_variable
score 54 59 54 59 I-clinical_variable
( 60 61 60 61 O
0 61 62 61 62 O
- 62 63 62 63 O
17 63 65 63 65 B-upper_bound
) 65 66 65 66 O
Oncotype 67 75 67 75 O
is 76 78 76 78 O
not 79 82 79 82 O
required 83 91 83 91 O
for 92 95 92 95 O
women 96 101 96 101 B-gender
diagnosed 102 111 102 111 O
with 112 116 112 116 O
DCIS 117 121 117 121 B-cancer

Biopsy 0 6 122 128 B-treatment
tissue 7 13 129 135 O
( 14 15 136 137 O
either 15 21 137 143 O
slides 22 28 144 150 O
or 29 31 151 153 O
block 32 37 154 159 O
) 37 38 159 160 O
from 39 43 161 165 O
outside 44 51 166 173 O
institutions 52 64 174 186 O
will 65 69 187 191 O
be 70 72 192 194 O
reviewed 73 81 195 203 O
to 82 84 204 206 O
confirm 85 92 207 214 O
diagnosis 93 102 215 224 O

Breast 0 6 225 231 B-treatment
implant 7 14 232 239 I-treatment
in 15 17 240 242 I-treatment
the 18 21 243 246 I-treatment
breast 22 28 247 253 I-treatment
to 29 31 254 256 O
be 32 34 257 259 O
treated 35 42 260 267 O
with 43 47 268 272 O
SBRT 48 52 273 277 B-treatment

Breast 0 6 278 284 O
preservation 7 19 285 297 O
candidates 20 30 298 308 O
( 31 32 309 310 O
no 32 34 310 312 O
prior 35 40 313 318 B-treatment
breast 41 47 319 325 I-treatment
or 48 50 326 328 I-treatment
nodal 51 56 329 334 I-treatment
radiotherapy 57 69 335 347 I-treatment
, 69 70 347 348 O
no 71 73 349 351 O
imaging 74 81 352 359 O
evidence 82 90 360 368 O
of 91 93 369 371 O
multicentric 94 106 372 384 O
or 107 109 385 387 O
multifocal 110 120 388 398 O
disease 121 128 399 406 O
, 128 129 406 407 O
no 130 132 408 410 O
pregnant 133 141 411 419 B-pregnancy
women 142 147 420 425 B-gender
, 147 148 425 426 O
and 149 152 427 430 O
no 153 155 431 433 O
comorbid 156 164 434 442 O
conditions 165 175 443 453 O
precluding 176 186 454 464 O
surgery 187 194 465 472 B-treatment
) 194 195 472 473 O

Clinical 0 8 474 482 O
T1N0M0 9 15 483 489 O
invasive 16 24 490 498 B-cancer
carcinoma 25 34 499 508 I-cancer

Ductal 0 6 509 515 B-clinical_variable
carcinoma 7 16 516 525 I-clinical_variable
in 17 19 526 528 I-clinical_variable
situ 20 24 529 533 I-clinical_variable
( 25 26 534 535 I-clinical_variable
DCIS 26 30 535 539 I-clinical_variable
) 30 31 539 540 I-clinical_variable
< 32 33 541 542 O
or 34 36 543 545 O
equal 37 42 546 551 O
to 43 45 552 554 O
2 46 47 555 556 B-upper_bound
cm 47 49 556 558 I-upper_bound

Eligible 0 8 559 567 O
for 9 12 568 571 O
contrasted 13 23 572 582 O
magnetic 24 32 583 591 O
resonance 33 42 592 601 O
imaging 43 50 602 609 O
( 51 52 610 611 O
MRI 52 55 611 614 O
) 55 56 614 615 O
on 57 59 616 618 O
initial 60 67 619 626 O
evaluation 68 78 627 637 O
with 79 83 638 642 O
glomerular 84 94 643 653 B-clinical_variable
filtration 95 105 654 664 I-clinical_variable
rate 106 110 665 669 I-clinical_variable
( 111 112 670 671 I-clinical_variable
GFR 112 115 671 674 I-clinical_variable
) 115 116 674 675 I-clinical_variable
â‰¥ 117 118 676 677 O
60 119 121 678 680 B-lower_bound
ml 122 124 681 683 I-lower_bound
/ 124 125 683 684 I-lower_bound
min 125 128 684 687 I-lower_bound

Estrogen 0 8 688 696 O
receptor 9 17 697 705 O
positive 18 26 706 714 O
( 27 28 715 716 O
ER+ 28 31 716 719 O
) 31 32 719 720 O
, 32 33 720 721 O
Human 34 39 722 727 O
epidermal 40 49 728 737 O
growth 50 56 738 744 O
factor 57 63 745 751 O
2 64 65 752 753 O
negative 66 74 754 762 O
( 75 76 763 764 O
HER2- 76 81 764 769 O
) 81 82 769 770 O
HER-2 83 88 771 776 O
status 89 95 777 783 O
is 96 98 784 786 O
not 99 102 787 790 O
required 103 111 791 799 O
for 112 115 800 803 O
women 116 121 804 809 B-gender
diagnosed 122 131 810 819 O
with 132 136 820 824 O
DCIS 137 141 825 829 B-cancer

Female 0 6 830 836 B-gender
subjects 7 15 837 845 I-gender
must 16 20 846 850 O
agree 21 26 851 856 B-contraception_consent
to 27 29 857 859 I-contraception_consent
use 30 33 860 863 I-contraception_consent
a 34 35 864 865 I-contraception_consent
medically 36 45 866 875 I-contraception_consent
acceptable 46 56 876 886 I-contraception_consent
contraceptives 57 71 887 901 I-contraception_consent
including 72 81 902 911 O

HER2 0 4 912 916 B-cancer
positive 5 13 917 925 I-cancer

Medical 0 7 926 933 O
conditions 8 18 934 944 O
that 19 23 945 949 O
may 24 27 950 953 O
increase 28 36 954 962 O
risk 37 41 963 967 O
for 42 45 968 971 O
poor 46 50 972 976 O
cosmetic 51 59 977 985 O
outcome 60 67 986 993 O
( 68 69 994 995 O
i.e. 69 73 995 999 O
Lupus 74 79 1000 1005 B-chronic_disease
, 79 80 1005 1006 O
rheumatoid 81 91 1007 1017 B-chronic_disease
arthritis 92 101 1018 1027 I-chronic_disease
, 101 102 1027 1028 O
scleroderma 103 114 1029 1040 B-chronic_disease
) 114 115 1040 1041 O

Neoadjuvant 0 11 1042 1053 B-treatment
chemotherapy 12 24 1054 1066 I-treatment

Positive 0 8 1067 1075 B-pregnancy
serum 9 14 1076 1081 I-pregnancy
pregnancy 15 24 1082 1091 I-pregnancy
test 25 29 1092 1096 O

Subjects 0 8 1097 1105 O
unable 9 15 1106 1112 O
to 16 18 1113 1115 O
receive 19 26 1116 1123 O
study 27 32 1124 1129 O
treatment 33 42 1130 1139 B-treatment
planning 43 51 1140 1148 O
secondary 52 61 1149 1158 O
to 62 64 1159 1161 O
body 65 69 1162 1166 O
habitus 70 77 1167 1174 O
or 78 80 1175 1177 O
inability 81 90 1178 1187 O
to 91 93 1188 1190 O
lie 94 97 1191 1194 O
flat 98 102 1195 1199 O
on 103 105 1200 1202 O
the 106 109 1203 1206 O
stomach 110 117 1207 1214 O
at 118 120 1215 1217 O
length 121 127 1218 1224 O

White 0 5 1225 1230 B-clinical_variable
blood 6 11 1231 1236 I-clinical_variable
cells 12 17 1237 1242 I-clinical_variable
( 18 19 1243 1244 I-clinical_variable
WBC 19 22 1244 1247 I-clinical_variable
) 22 23 1247 1248 I-clinical_variable
> 24 25 1249 1250 O
3000 26 30 1251 1255 B-lower_bound
, 30 31 1255 1256 O
Hemoglobin 32 42 1257 1267 B-clinical_variable
( 43 44 1268 1269 I-clinical_variable
Hgb 45 48 1270 1273 I-clinical_variable
) 48 49 1273 1274 I-clinical_variable
> 50 51 1275 1276 O
9 52 53 1277 1278 B-lower_bound
, 53 54 1278 1279 O
platelets 55 64 1280 1289 B-clinical_variable
> 65 66 1290 1291 O
100000 66 72 1291 1297 B-lower_bound
within 73 79 1298 1304 O
30 80 82 1305 1307 B-upper_bound
days 83 87 1308 1312 I-upper_bound
of 88 90 1313 1315 O
consent 91 98 1316 1323 O

Women 0 5 1324 1329 B-gender
of 6 8 1330 1332 O
child 9 14 1333 1338 O
- 14 15 1338 1339 O
bearing 15 22 1339 1346 O
potential 23 32 1347 1356 O
must 33 37 1357 1361 O
consent 38 45 1362 1369 B-contraception_consent
to 46 48 1370 1372 I-contraception_consent
use 49 52 1373 1376 I-contraception_consent
adequate 53 61 1377 1385 I-contraception_consent
contraception 62 75 1386 1399 I-contraception_consent
during 76 82 1400 1406 O
the 83 86 1407 1410 O
course 87 93 1411 1417 O
of 94 96 1418 1420 O
the 97 100 1421 1424 O
study 101 106 1425 1430 O

Women 0 5 1431 1436 B-gender
with 6 10 1437 1441 O
a 11 12 1442 1443 O
biopsy 13 19 1444 1450 B-treatment
proven 20 26 1451 1457 O
diagnosis 27 36 1458 1467 O
of 37 39 1468 1470 O
ductal 40 46 1471 1477 B-cancer
carcinoma 47 56 1478 1487 I-cancer
in 57 59 1488 1490 I-cancer
situ 60 64 1491 1495 I-cancer
or 65 67 1496 1498 O
invasive 68 76 1499 1507 B-cancer
carcinoma 77 86 1508 1517 I-cancer
of 87 89 1518 1520 I-cancer
the 90 93 1521 1524 I-cancer
breast 94 100 1525 1531 I-cancer

an 0 2 1532 1534 O
intrauterine 3 15 1535 1547 B-contraception_consent
device 16 22 1548 1554 I-contraception_consent
( 23 24 1555 1556 I-contraception_consent
IUD 24 27 1556 1559 I-contraception_consent
) 27 28 1559 1560 I-contraception_consent

surgical 0 8 1561 1569 B-treatment
sterilization 9 22 1570 1583 I-treatment
( 23 24 1584 1585 O
such 24 28 1585 1589 O
as 29 31 1590 1592 O
a 32 33 1593 1594 O
tubal 34 39 1595 1600 B-treatment
ligation 40 48 1601 1609 I-treatment
or 49 51 1610 1612 O
hysterectomy 52 64 1613 1625 B-treatment
) 64 65 1625 1626 O

